stoxline Quote Chart Rank Option Currency Glossary
  
Cybin Inc. (CYBN)
8.32  -0.14 (-1.65%)    07-18 16:00
Open: 8.445
High: 8.5
Volume: 435,995
  
Pre. Close: 8.46
Low: 8.1597
Market Cap: 175(M)
Technical analysis
2025-07-18 4:40:20 PM
Short term     
Mid term     
Targets 6-month :  10.26 1-year :  11.48
Resists First :  8.79 Second :  9.82
Pivot price 7.88
Supports First :  7.11 Second :  5.91
MAs MA(5) :  7.84 MA(20) :  7.91
MA(100) :  7.38 MA(250) :  8.84
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  32.1 D(3) :  21.5
RSI RSI(14): 55.3
52-week High :  13.88 Low :  4.8
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CYBN ] has closed below upper band by 26.6%. Bollinger Bands are 11.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 8.51 - 8.56 8.56 - 8.6
Low: 8.05 - 8.1 8.1 - 8.15
Close: 8.24 - 8.33 8.33 - 8.41
Company Description

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Headline News

Fri, 18 Jul 2025
Wall Street Analysts See an 831.44% Upside in Cybin Inc. (CYBN): Can the Stock Really Move This High? - Yahoo Finance

Thu, 17 Jul 2025
Three High-Risk, High-Reward Stocks in AI, Biotech, and Autonomous Vehicles - AInvest

Thu, 17 Jul 2025
Major Breakthrough: Cybin's Depression Drug Enters Global Phase 3 Trial After UK Green Light - Stock Titan

Wed, 16 Jul 2025
Three High-Risk, High-Reward Stocks with Explosive Upside: Rezolve AI, Aurora Innovation, and Cybin Inc. - AInvest

Fri, 11 Jul 2025
Cybin: Upgrade To Hold - But Don't Get Too Carried Away (NYSE:CYBN) - Seeking Alpha

Mon, 30 Jun 2025
Cybin Inc. Advances Mental Health Innovations with Strategic Partnerships and Clinical Progress - TipRanks

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 760 (M)
Shares Float 574 (M)
Held by Insiders 6.9 (%)
Held by Institutions 38.3 (%)
Shares Short 14,900 (K)
Shares Short P.Month 12,740 (K)
Stock Financials
EPS -0.16
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.37
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -32.8 %
Return on Equity (ttm) -49.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.12
Qtrly Earnings Growth 0 %
Operating Cash Flow -85 (M)
Levered Free Cash Flow -50 (M)
Stock Valuations
PE Ratio -55.47
PEG Ratio 0
Price to Book value 22.48
Price to Sales 0
Price to Cash Flow -74
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android